標(biāo)題: Titlebook: Botulinum Toxin Treatment in Clinical Medicine; A Disease-Oriented A Bahman Jabbari Book 2018 Springer International Publishing AG 2018 Bot [打印本頁(yè)] 作者: CRUST 時(shí)間: 2025-3-21 18:07
書目名稱Botulinum Toxin Treatment in Clinical Medicine影響因子(影響力)
書目名稱Botulinum Toxin Treatment in Clinical Medicine影響因子(影響力)學(xué)科排名
書目名稱Botulinum Toxin Treatment in Clinical Medicine網(wǎng)絡(luò)公開度
書目名稱Botulinum Toxin Treatment in Clinical Medicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Botulinum Toxin Treatment in Clinical Medicine被引頻次
書目名稱Botulinum Toxin Treatment in Clinical Medicine被引頻次學(xué)科排名
書目名稱Botulinum Toxin Treatment in Clinical Medicine年度引用
書目名稱Botulinum Toxin Treatment in Clinical Medicine年度引用學(xué)科排名
書目名稱Botulinum Toxin Treatment in Clinical Medicine讀者反饋
書目名稱Botulinum Toxin Treatment in Clinical Medicine讀者反饋學(xué)科排名
作者: 憂傷 時(shí)間: 2025-3-21 21:02
Botulinum Toxin Treatment of Neuropathic Pain, syndrome, carpal tunnel syndrome, occipital neuralgia, and phantom limb pain are of low quality and controversial; hence, conduction of clinical trials of higher quality is required to determine if there is a therapeutic role for BoNTs in these conditions. The dosage and technique of injection, dil作者: 哭得清醒了 時(shí)間: 2025-3-22 01:26
Clinical Uses of Botulinum Toxin in the Skin,que and dosage varies from practice to practice based on the provider, but it is essential to know the underlying anatomy and muscles targeted. Equally important is the knowledge of potential side effects. Facial asymmetry and temporary functional impairment are real risks that should be incorporate作者: 對(duì)待 時(shí)間: 2025-3-22 07:55 作者: 深淵 時(shí)間: 2025-3-22 11:25
Springer Series on Environmental Managementn to improve efficacy. Based on results of small, short-term clinical trials, evidence for improvement of limb spasticity in children with CP has been established, but the evidence for improving function is less certain. There is a lack of evidence for long-term improvements in spasticity, function,作者: BILE 時(shí)間: 2025-3-22 15:56 作者: 結(jié)果 時(shí)間: 2025-3-22 18:06
General Formulas for Three-Body Resonancesque and dosage varies from practice to practice based on the provider, but it is essential to know the underlying anatomy and muscles targeted. Equally important is the knowledge of potential side effects. Facial asymmetry and temporary functional impairment are real risks that should be incorporate作者: Accessible 時(shí)間: 2025-3-23 00:27 作者: overreach 時(shí)間: 2025-3-23 03:51
Botulinum Toxin Treatment of Primary Dystonia, dystonia. The pathophysiology of this disorder is complex, but is known to involve circuits in the basal ganglia and cerebellum. Botulinum toxin (BoNT) is the treatment of choice for focal dystonia—including cervical dystonia, blepharospasm, and focal hand dystonia—and is useful for selected areas 作者: chalice 時(shí)間: 2025-3-23 08:13 作者: insert 時(shí)間: 2025-3-23 12:12 作者: 顯示 時(shí)間: 2025-3-23 15:14 作者: grudging 時(shí)間: 2025-3-23 20:59
Botulinum Toxin for Treatment of Spasticity in Cerebral Palsy,ons most often occur prenatally. Clinical presentations are heterogeneous; common features include hypertonia, movement disorders, and negative signs. These have a reciprocal interaction with growth and development causing evolving symptoms over time. Spasticity is the most common motor disorder aff作者: ineffectual 時(shí)間: 2025-3-23 23:07 作者: LUMEN 時(shí)間: 2025-3-24 05:54
Clinical Uses of the Botulinum Toxin and Ophthalmology,certain types of nystagmus, apraxia of the eyelid opening, eyelid myokyomia, facial nerve synkinesis, lacrimal hypersecretion syndromes, eyelid retraction, spastic entropion and corneal protective ptosis. In this chapter, I discuss these indications.作者: 卡死偷電 時(shí)間: 2025-3-24 08:20
Botulinum Toxin Treatment of Migraine and Other Headaches,fficacy of onabotulinumtoxinA in chronic migraine (15 or more times/month). Long-term follow-up of patients who have participated in the multicenter studies of chronic migraine (PREEMPT studies) have shown continued efficacy and tolerability and improvement of the quality of life after repeated botu作者: Terminal 時(shí)間: 2025-3-24 13:00
Botulinum Toxin Treatment of Neuropathic Pain,or response to analgesic medications. In this chapter, we discuss our current knowledge of the pathophysiology of NP followed by its conventional treatment and provide evidence-based comments on the efficacy of botulinum neurotoxins (BoNTs) in the management of NP. The published guidelines of the Am作者: Granular 時(shí)間: 2025-3-24 17:28
The Role of Botulinum Toxins in Treatment of Brain and Spinal Cord Injury Symptoms,ity; types of bladder dysfunction, movement disorders, and neuropathic pain are discussed in this chapter. The evidence-based literature on the efficacy of BoNT therapy for brain and spinal cord trauma-related symptoms is provided using the efficacy guidelines of the American Academy of Neurology.作者: Etching 時(shí)間: 2025-3-24 19:28 作者: Predigest 時(shí)間: 2025-3-25 01:37
Clinical Uses of Botulinum Toxin in the Skin,tions for facial rejuvenation. The earliest pioneer within the injectable family is the use of botulinum toxin for dynamic facial rhytids, or expression lines and wrinkles. Over the years, the area of utilization has expanded from the upper central face and forehead to more complex uses around the e作者: Excise 時(shí)間: 2025-3-25 05:52
The Role of Botulinum Toxins in Treatment of Cancer-Related Issues: Post-radiation and Post-surgicasory nerve fibers and post-radiation/post-surgical pain due to nervous system damage. Botulinum neurotoxins (BoNTs) exert their analgesic effect via impeding conduction at the neuromuscular junction as well as inhibition of the release of pain mediators from peripheral nerve endings, dorsal root gan作者: 品嘗你的人 時(shí)間: 2025-3-25 10:37 作者: erythema 時(shí)間: 2025-3-25 14:03 作者: GIST 時(shí)間: 2025-3-25 17:20
Book 2018f the disease and its current treatment followed by an evidenced-based upon the published assertions of the Therapeutic Subcommittee of the American Academy of Neurology. ?Each chapter includes case histories from editor’s vast experience of over 25 years with BoNT therapy and description of injecti作者: canvass 時(shí)間: 2025-3-25 23:01 作者: BACLE 時(shí)間: 2025-3-26 01:39
Jean-Claude Duplessy,Laurent D. Labeyriesfactory relief. BoNT is helpful in the management of blepharospasm, bruxism, camptocormia, cervical dystonia including anterocollis, sialorrhea, seborrhea, and overactive bladder. BoNT is a safe and effective therapy for this patient population when administered by skilled physicians.作者: ADORE 時(shí)間: 2025-3-26 05:17 作者: Narrative 時(shí)間: 2025-3-26 10:15
,Botulinum Toxin Treatment in Parkinson’s Disease and Atypical Parkinsonian Disorders,sfactory relief. BoNT is helpful in the management of blepharospasm, bruxism, camptocormia, cervical dystonia including anterocollis, sialorrhea, seborrhea, and overactive bladder. BoNT is a safe and effective therapy for this patient population when administered by skilled physicians.作者: 易于出錯(cuò) 時(shí)間: 2025-3-26 15:24
Botulinum Toxin Treatment in Cerebrovascular Disease,isorders, and sialorrhea, all potentially amenable to botulinum neurotoxin (BoNT) therapy. Evidence-based data on the efficacy of BoNTs in treatment of each of these disorders will be presented and discussed.作者: Ordnance 時(shí)間: 2025-3-26 17:11
Modeling Long-Term Climatic Changesoveractive bladder in 2013. Following regulatory approval, use of BoNTA has gained popularity among urologists. This chapter outlines applications of BoNTA in the management of lower urinary tract disorders and presents most recent data regarding efficacy, side effects, and cost-effectiveness of BoNTA in urologic applications.作者: 強(qiáng)制性 時(shí)間: 2025-3-26 23:03 作者: 宣稱 時(shí)間: 2025-3-27 03:11
https://doi.org/10.1007/978-3-642-79066-9mproved understanding of their unique biological properties, will open up a huge opportunity to identify new therapeutic BoNTs with an improved feature with respect to the toxins available on the market or to be exploited for new clinical applications.作者: antidepressant 時(shí)間: 2025-3-27 08:55 作者: aerobic 時(shí)間: 2025-3-27 10:23 作者: defeatist 時(shí)間: 2025-3-27 15:14
https://doi.org/10.1007/978-1-4419-9308-3 selection of rigid primary outcome criteria, application of low doses, and suboptimal techniques. Anecdotal observations suggest efficacy in cluster headaches and some forms of secondary headaches (post-traumatic) but as yet no randomized clinical trials are available for this form of headaches.作者: Nebulous 時(shí)間: 2025-3-27 20:47
The Role of Remote Sensing in LTER Projects most common guidance techniques for BoNT therapy including anatomic or manual guidance and the instrumented guidance techniques of electromyography (EMG), electrical stimulation (E-Stim), ultrasound (US), and fluoroscopy (Flouro), including discussion of the current level of evidence for the advantages and limitations of each technique.作者: 庇護(hù) 時(shí)間: 2025-3-28 01:45
Botulinum Toxins: Molecular Structures and Synaptic Physiology,mproved understanding of their unique biological properties, will open up a huge opportunity to identify new therapeutic BoNTs with an improved feature with respect to the toxins available on the market or to be exploited for new clinical applications.作者: Crater 時(shí)間: 2025-3-28 04:25
Botulinum Toxin Treatment of Primary Dystonia,NT is limited by both dosing and by the occurrence of side effects which are due to spread of the toxin into adjacent muscles. The type of side effect(s) depends on the areas injected, but can include ptosis, diplopia, hematoma at the injection site, neck weakness, and dysphagia.作者: 龍卷風(fēng) 時(shí)間: 2025-3-28 09:55
The Role of Botulinum Toxin in the Gastrointestinal Tract,ulinum toxin is now used for a variety of spastic smooth muscle disorders of the GI tract. In some instances, this therapy may preclude the need for more invasive treatments. Controlled trials are needed.作者: Introvert 時(shí)間: 2025-3-28 11:20 作者: 使成核 時(shí)間: 2025-3-28 17:54 作者: terazosin 時(shí)間: 2025-3-28 22:02
Book 2018usses molecular structure, mechanism of action, toxin serotypes, immunogenicity and safety issues. Meanwhile, a concluding chapter provides information on potential future application of these toxins’ for treating symptoms of other specific diseases. ?作者: 繞著哥哥問(wèn) 時(shí)間: 2025-3-29 02:48
John Tomblin,Lamia Salah,Dan Hoffmany of BoNT therapy in several other symptoms caused by MS: certain tremors, myokymia, tonic spasms, spastic dysphagia, and internuclear ophthalmoplegia. The data on MS-related sialorrhea are not available.作者: 先鋒派 時(shí)間: 2025-3-29 06:17 作者: affluent 時(shí)間: 2025-3-29 09:33
Botulinum Toxin Treatment in Multiple Sclerosis,y of BoNT therapy in several other symptoms caused by MS: certain tremors, myokymia, tonic spasms, spastic dysphagia, and internuclear ophthalmoplegia. The data on MS-related sialorrhea are not available.作者: 牌帶來(lái) 時(shí)間: 2025-3-29 13:09 作者: dictator 時(shí)間: 2025-3-29 18:49 作者: 錯(cuò)事 時(shí)間: 2025-3-29 21:58 作者: Recessive 時(shí)間: 2025-3-30 03:15
Clinical Uses of the Botulinum Toxin and Ophthalmology,certain types of nystagmus, apraxia of the eyelid opening, eyelid myokyomia, facial nerve synkinesis, lacrimal hypersecretion syndromes, eyelid retraction, spastic entropion and corneal protective ptosis. In this chapter, I discuss these indications.作者: 巨碩 時(shí)間: 2025-3-30 05:16
The Role of Botulinum Toxins in Treatment of Brain and Spinal Cord Injury Symptoms,ity; types of bladder dysfunction, movement disorders, and neuropathic pain are discussed in this chapter. The evidence-based literature on the efficacy of BoNT therapy for brain and spinal cord trauma-related symptoms is provided using the efficacy guidelines of the American Academy of Neurology.作者: Limerick 時(shí)間: 2025-3-30 10:50
Botulinum Toxin Therapy: Future Perspectives,s in which, in the author’s opinion, botulinum toxin has a potential to make a major impact in patient care. The disciplines likely to benefit from the use of botulinum toxins include Orthopedics (ostheoarthritis), Cardiology (atrial fibrillation), Psychiatry (depression), and Autonomic System (prevention of radiation damage to salivary glands).作者: 非秘密 時(shí)間: 2025-3-30 14:21
Bahman JabbariFeatures a unique, disease-oriented approach to botulinum toxin.Provides information on the effect of the toxin on both individual symptoms and the disease as a whole.Includes case reports, technical 作者: 蝕刻術(shù) 時(shí)間: 2025-3-30 18:15 作者: 顛簸下上 時(shí)間: 2025-3-30 21:03 作者: DRAFT 時(shí)間: 2025-3-31 01:19
Biosphere Modeling for Climate Studies dystonia. The pathophysiology of this disorder is complex, but is known to involve circuits in the basal ganglia and cerebellum. Botulinum toxin (BoNT) is the treatment of choice for focal dystonia—including cervical dystonia, blepharospasm, and focal hand dystonia—and is useful for selected areas 作者: 共同確定為確 時(shí)間: 2025-3-31 06:05
Jean-Claude Duplessy,Laurent D. Labeyrieve conditions in which BoNT has emerged as a therapeutic option for many symptoms, especially when other medical therapies have failed to provide satisfactory relief. BoNT is helpful in the management of blepharospasm, bruxism, camptocormia, cervical dystonia including anterocollis, sialorrhea, sebo作者: 以煙熏消毒 時(shí)間: 2025-3-31 10:50
Modeling Long-Term Climatic Changesc detrusor overactivity and non-neurogenic overactive bladder. Following several randomized controlled trials with promising outcomes, the US Food and Drug Administration approved application of BoNTA for treatment of urge urinary incontinence due to neurogenic detrusor overactivity in 2011 and for 作者: BINGE 時(shí)間: 2025-3-31 15:22 作者: 六個(gè)才偏離 時(shí)間: 2025-3-31 18:45 作者: myalgia 時(shí)間: 2025-4-1 01:16
John Tomblin,Lamia Salah,Dan Hoffman a myriad of clinical symptoms. The symptomatic treatment of multiple sclerosis often does not meet patient’s satisfaction despite the availability of a variety of pharmacotherapeutic agents. This evidence-based review discusses the utility of botulinum neurotoxin therapy for treating the symptoms o作者: 外形 時(shí)間: 2025-4-1 02:17 作者: panorama 時(shí)間: 2025-4-1 09:43
